Durvalumab
Anti-Durvalumab Recombinant Antibody Products
-
- Specificity: Durvalumab
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, PK/PD, ADA control
Compare
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Durvalumab is a human IgG1 kappa monoclonal antibody and immune-checkpoint inhibitor approved for use with etoposide and either carboplatin or cisplatin as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC).